Hundreds of IPOs Stuck in Logjam Amid Tightened Regulatory Reviews (Caixin)

Backlogs of applications for initial public offerings reemerged in China as regulators tightened scrutiny following Ant Group’s surprise listing suspension, forcing several companies to cancel their share sale plans.

A total of 14 companies that planned to list on mainland bourses have had their listing processes terminated so far this year, and at least seven of them withdrew their applications voluntarily, data from the Shanghai and Shenzhen exchanges show. READ MORE (CACHED ARTICLE)

Similar Posts:

• Podcast: A Beginner’s Guide to Investing in China (KraneShares)
• What if America Delists Chinese Firms? (The Asset)
• China Tech Giants Accused of ‘Bullying’ Consumers with Algorithms (Caixin)
• Understanding China’s Recent Moves in Its Capital Markets (Ray Dalio)
• Billion-dollar Tech Startups Hold Promise for China’s Economy (Nikkei Asian Review)
• Push for US-listed China Firms to Disclose Interference Risks (The Standard)
• Asia is Home to 50% of World’s Fastest Growing Companies (Nikkei Asian Review)
• The 40 Biggest Chinese Stocks Being Added to the MSCI Index (Fortune)
• Investors Could Short Hong Kong to Hedge Long Shanghai Positions (BOCOM International)
• Chart of the Day: Chinese Bourses Top IPO League Tables (Caixin)
• Why Would the Chinese Pay $1B for a Talking Cat Game? (BloombergBusinessweek)
• What is the SEC Targeting Alibaba (BABA) About? (China Accounting Blog)
• Fund Manager Consensus: Hong Kong Needs China More Than Vice Versa (AsianInvestor)
• Hong Kong Stocks Roar Into 2021 on Surge of Investment From China (Nikkei Asia)
• Be Wary of the MSCI China Inclusion Hype (WSJ)